FDAnews
www.fdanews.com/articles/197960-regeneron-lands-450-million-federal-contract-for-covid-19-antibody-cocktail
Regeneron logo

Regeneron Lands $450 Million Federal Contract for COVID-19 Antibody Cocktail

July 8, 2020

Regeneron Pharmaceuticals has been granted a $450 million contract with HHS and the Department of Defense to manufacture and supply its antibody cocktail REGN-COV2 for the treatment of COVID-19 patients.

The contract is the first granted under the Trump administration’s Operation Warp Speed to support development and manufacturing of a potential COVID-19 therapeutic.

The dual antibody cocktail entered a phase 3 trial this week to assess its ability to prevent infection among people exposed to coronavirus patients.

View today's stories